Barclays raised the firm’s price target on Compass to $5 from $4 and keeps an Equal Weight rating on the shares. The company’s Q2 EBITDA came in ahead of guide with solid spending control, the analyst tells investors in a research note. The firm says the long-term effects of NAR lawsuit on commission rates is still unclear.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on COMP: